AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin
Mei Gao(State Key Laboratory of Biotherapy), Yangfu Jiang(Sichuan University)
Cited by 44
Related Papers
Targeting mTOR for cancer therapy
|Journal of Hematology & Oncology|2019|921
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
|Journal of Hematology & Oncology|2022|455
mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR
|Cell Research|2015|143
Gamma synuclein is a novel Twist1 target that promotes TGF-β-induced cancer cell migration and invasion
|Cell Death and Disease|2018|57
Inhibition of eIF2α dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells
|Cell Death and Disease|2014|56